| Primary |
| Gout |
30.9% |
| Product Used For Unknown Indication |
22.7% |
| Hyperuricaemia |
15.5% |
| Hypertension |
5.2% |
| Diabetes Mellitus |
4.1% |
| Drug Use For Unknown Indication |
4.1% |
| Hyperuricemia |
3.1% |
| Tumour Lysis Syndrome |
3.1% |
| Basedow's Disease |
1.0% |
| Gouty Arthropathy |
1.0% |
| Gouty Tophus |
1.0% |
| Hyperlipidaemia |
1.0% |
| Hypothyroidism |
1.0% |
| Nephrolithiasis |
1.0% |
| Pain |
1.0% |
| Polymyalgia Rheumatica |
1.0% |
| Tracheitis |
1.0% |
| Urate Nephropathy |
1.0% |
| Uric Acid Increased |
1.0% |
|
| Cardiac Failure |
12.5% |
| Visual Impairment |
9.4% |
| Death |
6.3% |
| General Physical Health Deterioration |
6.3% |
| Pruritus |
6.3% |
| Rash Generalised |
6.3% |
| Rash Maculo-papular |
6.3% |
| Rhabdomyolysis |
6.3% |
| Vomiting |
6.3% |
| Anosmia |
3.1% |
| Anuria |
3.1% |
| Atrioventricular Block Second Degree |
3.1% |
| Basedow's Disease |
3.1% |
| Blindness |
3.1% |
| Cardiac Arrest |
3.1% |
| Drug Level Increased |
3.1% |
| Faecal Incontinence |
3.1% |
| Headache |
3.1% |
| Hypersensitivity |
3.1% |
| Hypertensive Crisis |
3.1% |
|
| Secondary |
| Product Used For Unknown Indication |
34.0% |
| Gout |
13.4% |
| Hypertension |
11.3% |
| Gouty Arthritis |
5.2% |
| Diabetes Mellitus |
4.1% |
| Hyperlipidaemia |
4.1% |
| Urate Nephropathy |
4.1% |
| Corneal Transplant |
3.1% |
| Arthritis |
2.1% |
| Atrial Fibrillation |
2.1% |
| Cardiovascular Event Prophylaxis |
2.1% |
| Coronary Artery Disease |
2.1% |
| Epilepsy |
2.1% |
| Osteoarthritis |
2.1% |
| Pain |
2.1% |
| Urinary Tract Infection |
2.1% |
| Arthralgia |
1.0% |
| Chronic Myeloid Leukaemia |
1.0% |
| Clostridial Infection |
1.0% |
| Deep Vein Thrombosis |
1.0% |
|
| Oedema Peripheral |
16.0% |
| Renal Failure Acute |
12.0% |
| Rhabdomyolysis |
12.0% |
| Alanine Aminotransferase Increased |
4.0% |
| Anosmia |
4.0% |
| Blindness Unilateral |
4.0% |
| Coronary Artery Disease |
4.0% |
| Hypertensive Crisis |
4.0% |
| Organising Pneumonia |
4.0% |
| Pyrexia |
4.0% |
| Rash |
4.0% |
| Rash Maculo-papular |
4.0% |
| Renal Failure |
4.0% |
| Retinal Artery Occlusion |
4.0% |
| Tachycardia |
4.0% |
| Transaminases Increased |
4.0% |
| Tubulointerstitial Nephritis |
4.0% |
| Vomiting |
4.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.2% |
| Hypertension |
20.1% |
| Diabetes Mellitus |
10.0% |
| Renal Failure |
6.5% |
| Gout |
5.0% |
| Hyperuricaemia |
3.6% |
| Rheumatoid Arthritis |
3.6% |
| Hyperlipidaemia |
2.9% |
| Hypothyroidism |
2.5% |
| Type 2 Diabetes Mellitus |
2.5% |
| Extrapyramidal Disorder |
2.2% |
| Prophylaxis |
2.2% |
| Insomnia |
1.8% |
| Atrial Fibrillation |
1.4% |
| Bipolar I Disorder |
1.4% |
| Colorectal Cancer Metastatic |
1.4% |
| Gastritis |
1.4% |
| Insulin-requiring Type 2 Diabetes Mellitus |
1.4% |
| Neuropathy Peripheral |
1.4% |
| Peripheral Arterial Occlusive Disease |
1.4% |
|
| Vomiting |
11.1% |
| Dermatitis Psoriasiform |
8.3% |
| Angina Pectoris |
5.6% |
| Eating Disorder |
5.6% |
| Electrocardiogram Qt Prolonged |
5.6% |
| Iron Deficiency Anaemia |
5.6% |
| Metabolic Syndrome |
5.6% |
| Normochromic Normocytic Anaemia |
5.6% |
| Orthostatic Hypotension |
5.6% |
| Rash |
5.6% |
| Renal Failure |
5.6% |
| Syncope |
5.6% |
| Toxic Skin Eruption |
5.6% |
| Angioedema |
2.8% |
| Anuria |
2.8% |
| Aplasia |
2.8% |
| Atrioventricular Block Complete |
2.8% |
| Blood Pressure Diastolic Decreased |
2.8% |
| Bradycardia |
2.8% |
| Death |
2.8% |
|
| Interacting |
| Hypertension |
50.0% |
| Gastrooesophageal Reflux Disease |
25.0% |
| Gout |
25.0% |
|
| Rhabdomyolysis |
50.0% |
| Tendon Rupture |
50.0% |
|
